Articles

"We've seen about 20 homes, and put in two offers that didn't work out for various reasons."

Eli Lilly's Mounjaro is significantly more effective than Novo Nordisk's Ozempic in producing weight loss, a real-world study found

U.S. new-home sales fell 5.6% to a seasonally adjusted annual rate of 679,000 in October, from a revised 719,000 in the prior month, the government reported Monday. Analysts polled by the Wall Street Journal had forecast a seasonally adjusted annual rate of 725,000 in October.

Deutsche Bank's forecast for the S&P 500 to reach 5,100 in 2024 is among the highest on Wall Street so far this year.

Shopify 's stock shot higher Monday, fueled by data showing online holiday shopping got off to a strong start on Black Friday.

Xenon Pharmaceuticals shares fell early Monday after the company released new clinical-trial data on an experimental depression treatment.

Shares in Rightmove jumped 6% on Monday, after the U.K.'s biggest property portal raised its revenue guidance for the year as desperate sellers spent more to advertise their homes.

UBS is expecting GE HealthCare's margins to disappoint investors.

Italy's UniCredit is no longer among the world's globally systemically important banks.

Oil futures fall Monday as traders await a meeting of OPEC+ producers that was postponed from last week.

Don't base your financial plan on macro predictions about the economy and geopolitical developments.

These potential tax-loss losers could be primed for big gains in January.